 |
Previous Article | Next Article 
The Journal of Neuroscience, August 1, 2001, 21(15):5389-5396
Inflammatory Genes Are Upregulated in Expanded
Ataxin-3-Expressing Cell Lines and Spinocerebellar Ataxia Type 3 Brains
Bernd O.
Evert1,
Ina R.
Vogt1,
Claudia
Kindermann1,
Lucia
Ozimek1,
Rob A. I.
de
Vos2,
Ewout R. P.
Brunt3,
Ina
Schmitt1,
Thomas
Klockgether1, and
Ullrich
Wüllner1
1 Department of Neurology, University of Bonn, 53105 Bonn, Germany, 2 Laboratorium Pathologie Oost Nederland,
7512 AD Enschede, The Netherlands, and 3 Department of
Neurology, University of Groningen, 9713 AW Groningen, The Netherlands
Spinocerebellar ataxia type 3 (SCA3) is a polyglutamine disorder
caused by a CAG repeat expansion in the coding region of a gene
encoding ataxin-3. To study putative alterations of gene expression
induced by expanded ataxin-3, we performed PCR-based cDNA subtractive
hybridization in a cell culture model of SCA3. In rat mesencephalic
CSM14.1 cells stably expressing expanded ataxin-3, we found a
significant upregulation of mRNAs encoding the endopeptidase matrix
metalloproteinase 2 (MMP-2), the transmembrane protein amyloid
precursor protein, the interleukin-1 receptor-related Fos-inducible transcript, and the cytokine stromal cell-derived factor
1 (SDF1 ). Immunohistochemical studies of the corresponding or
associated proteins in human SCA3 brain tissue confirmed these findings, showing increased expression of MMP-2 and amyloid -protein (A ) in pontine neurons containing nuclear inclusions. In addition, extracellular A -immunoreactive deposits were detected in human SCA3
pons. Furthermore, pontine neurons of SCA3 brains strongly expressed
the antiinflammatory interleukin-1 receptor antagonist, the
proinflammatory cytokine interleukin-1 , and the proinflammatory chemokine SDF1. Finally, increased numbers of reactive astrocytes and
activated microglial cells were found in SCA3 pons. These results
suggest that inflammatory processes are involved in the pathogenesis of SCA3.
Key words:
spinocerebellar ataxia 3; polyglutamine disease; neurodegeneration; cell death; inflammation; gene expression; ataxin-3
Copyright © 2001 Society for Neuroscience 0270-6474/01/21155389-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
J. Gardiner, D. Barton, J. May Vanslambrouck, F. Braet, D. Hall, J. Marc, and R. Overall
Defects in Tongue Papillae and Taste Sensation Indicate a Problem with Neurotrophic Support in Various Neurological Diseases
Neuroscientist,
June 1, 2008;
14(3):
240 - 250.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. O. Evert, J. Araujo, A. M. Vieira-Saecker, R. A. I. de Vos, S. Harendza, T. Klockgether, and U. Wullner
Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation.
J. Neurosci.,
November 1, 2006;
26(44):
11474 - 11486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Berger, B. Ravikumar, F. M. Menzies, L. G. Oroz, B. R. Underwood, M. N. Pangalos, I. Schmitt, U. Wullner, B. O. Evert, C. J. O'Kane, et al.
Rapamycin alleviates toxicity of different aggregate-prone proteins
Hum. Mol. Genet.,
February 1, 2006;
15(3):
433 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Vernon and D. E. Griffin
Characterization of an In Vitro Model of Alphavirus Infection of Immature and Mature Neurons
J. Virol.,
March 15, 2005;
79(6):
3438 - 3447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Chalasani, F. Baribaud, C. M. Coughlan, M. J. Sunshine, V. M. Y. Lee, R. W. Doms, D. R. Littman, and J. A. Raper
The Chemokine Stromal Cell-Derived Factor-1 Promotes the Survival of Embryonic Retinal Ganglion Cells
J. Neurosci.,
June 1, 2003;
23(11):
4601 - 4612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Li, T. Macfarlan, R. N. Pittman, and D. Chakravarti
Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities
J. Biol. Chem.,
November 15, 2002;
277(47):
45004 - 45012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Rub, R. A. I. de Vos, C. Schultz, E. R. Brunt, H. Paulson, and H. Braak
Spinocerebellar ataxia type 3 (Machado-Joseph disease): severe destruction of the lateral reticular nucleus
Brain,
September 1, 2002;
125(9):
2115 - 2124.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|